Coenzyme Q10 (Ubiquinone/Ubiquinol)
CoQ10 is an essential electron carrier riding the mitochondrial electron-transport chain, complexes I through III, which is how your heart makes its ATP. It also moonlights as a lipid-phase antioxidant, regenerating vitamin E and keeping LDL from oxidizing. Here's the problem: heart failure depletes myocardial CoQ10 on its own, and statins pile on, blocking the mevalonate pathway that makes it in the first place. Your heart's fuel source and its own medication can both be working against its CoQ10 supply at the same time.
Evidence
Moderate, and the headline study here is Q-SYMBIO. That RCT, plus the meta-analyses that followed it, report reduced all-cause mortality, fewer major cardiac events, and better ejection fraction and functional class in people with chronic heart failure. That's not a small claim. Fewer people dying, plainly stated. Where it gets shakier is statin-associated muscle symptoms: meta-analyses on that front are genuinely mixed, so don't count on CoQ10 to fix statin muscle aches on its own.
Interactions
May blunt the effect of warfarin (CoQ10 is structurally similar to vitamin K), so INR should be monitored. Can modestly lower blood pressure, additive with antihypertensives.
Cautions
Generally well tolerated; mild GI upset possible. It is an adjunct, not a replacement, for guideline-directed heart-failure therapy or statins. Data do not support stopping a statin because of muscle symptoms without clinician input.
Food sources
Organ meats (heart, liver), fatty fish (sardines, mackerel), beef, and to a lesser extent nuts and some vegetable oils; dietary intake is small relative to supplemental doses.
